Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
Date:2/24/2009

diluted, compared to a net income of $0.29 per share, basic, and $0.25 per share, diluted, for the same period in 2007. Net income per share for the year ended December 31, 2008 was $0.95 per share, basic, and $0.83 per share, diluted, compared to net income of $1.37 per share, basic, and $1.21 per share, diluted, for the same period in 2007.

The primary drivers of the decrease in net income for the fourth quarter and year ended December 31, 2008 were the increase in R&D, SG&A and intangible amortization expenses, and lower interest income offset by the lower tax expense. Additionally, in the fourth quarter of 2008 we had a $2.3 million charge to write down to fair value our previous corporate headquarters which is currently held for sale.

Operating Highlights

During the three months and year ended December 31, 2008, net sales increased 4.9 percent and 14.0 percent, respectively, compared to the same periods in 2007.

The cost of sales for the three months and year ended December 31, 2008 increased $0.1 million and remained consistent, respectively, as compared to the same periods in 2007. For the three months and year ended December 31, 2008 the cost of sales was $2.1 million and $8.9 million, respectively, compared to $2.0 million and $8.9, respectively, for the same period in 2007.

Investment in our product pipeline and the company continued to grow as research and development (R&D) and selling, general and administrative (SG&A) expenses in the fourth quarter and year ended December 31, 2008 were $43.6 million and $131.7 million, respectively compared to $25.2 million and $72.9 million for the fourth quarter and year ended December 31, 2007, respectively. The quarter increases were due primarily to our investments in our infrastructure related to our development programs, costs to support the Cinryze open label trial and launch related costs, an
'/>"/>

SOURCE ViroPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ViroPharma to Present at Three November Healthcare Conferences
2. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
3. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
4. ViroPharma to Present at Three October Healthcare Conferences
5. ViroPharma to Present at Three September Healthcare Conferences
6. ViroPharma To Acquire Lev Pharmaceuticals
7. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
8. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
9. ViroPharma to Present at Two Upcoming Healthcare Conferences
10. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
11. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Nearly everyone has heard of the ... people realize that a rich source of these cells is teeth—baby teeth that come ... need to be pulled to make room for braces. These potent stem cells ...
(Date:7/28/2015)... YORK , July 28, 2015 People ... by hearing aids achieved significant and sometimes profound improvements ... cochlear implant devices, according to a new multicenter study ... In the study, described online ahead of print in ... medical centers and private clinics in the ...
(Date:7/28/2015)... ... ... VetStem Biopharma will be offering weekly private guided tours of our new facility, ... tour and course will be given every Wednesday at 6pm to local interested veterinarians ... are welcome to attend with their veterinarian as well. Participants will be able to ...
(Date:7/28/2015)... 28, 2015 BioStructures, LLC, a privately ... a milestone of 4,000 implantations of Signafuse® Bioactive ... in early 2014 as a bone void filler ... procedures.  This is a distinguished status among recently ... of new synthetic products have received clearance with ...
Breaking Biology Technology:Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Tooth™ Dental Stem Cell Banking Available to their Patients 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Revolutionary Bone Graft Exceeds Expectations 2
... June 24 NanoBio Corp. announced today,that it ... 15" list,designating NanoBio as one of the top ... FierceBiotech evaluated hundreds of privately held firms,based on ... of,technology, partnerships and competitive market position. NanoBio was,determined ...
... Inc., a,biopharmaceutical company engaged in the discovery and ... diseases, announced today,that it has been named to ... one of the top biotech companies of 2008. ... based on company,vision, revenue potential, quality of deals, ...
... Cardium Therapeutics,(Amex: CXM ) announced today that ... Microcap Index, according to the preliminary list of ... reconstitution of the,Russell Indexes will take place after ... (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ), Annual reconstitution of ...
Cached Biology Technology:FierceBiotech Names NanoBio Corporation as One of the 'Fierce 15' Biotech Companies of 2008 2Tolerx Named as One of the 'Fierce 15' Biotech Companies of 2008 2Tolerx Named as One of the 'Fierce 15' Biotech Companies of 2008 3Cardium Selected for Inclusion in Russell Microcap Index 2Cardium Selected for Inclusion in Russell Microcap Index 3Cardium Selected for Inclusion in Russell Microcap Index 4
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... has announced the addition of the "Natural ... Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image ... to their offering. The key vendors ... Google, HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, ...
(Date:6/30/2015)... 30, 2015 Genisphere announced ... to help further develop Genisphere,s therapeutics capabilities and portfolio. ... having spent much of the last 25 years in ... Bioscience, and Johnson & Johnson. Tom started his career ... Biotech Corporate Finance. He graduated from Dartmouth College with ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool ... toward a healthier, happier life. That,s exactly what USANA,s ... to do. The cutting-edge, portable health program provides a ... solutions to help improve your lifestyle and nutrition. ... dinner and gala Wednesday night, USANA,s THA was honored ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... discovered new communication channels in underwater environments and ... channels, will be honored later this month by ... work will eventually allow multiple users and underwater ... faster and more reliably in complex underwater environments. ...
... that raise the risk of type 1 diabetes. As ... puzzle for this disease, the researchers expect to improve ... add to our knowledge of the biology of type ... genetic risk, we will be able to develop better ...
... The accumulation of fat in the liver as a result ... according to a new study with mice. The research found ... liver of mice fed alcohol and, at the same time, ... broken down. Chronic alcohol consumption causes fat to ...
Cached Biology News:NJIT professor's research suggests changes in underwater data communications 2Researchers continue to find genes for type 1 diabetes 2Resveratrol prevents fat accumulation in livers of 'alcoholic' mice 2
One-step, microplate or cuvet, turbidometric, linear detection range 0.096 mg/dL to 11.5 mg/dL. Procedure: 5 min....
... for sizing single-stranded RNA ranging from 0.5 kb to ... ladder consists of nine bands in even increments (0.5 ... kb) to simplify size estimation. The 1.5 kb band ... orientation and identification of RNA bands on the gel. ...
Recombinant Mouse Wnt-3a...
Homo sapiens jumping translocation breakpoint...
Biology Products: